{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:48:33Z","timestamp":1791460113414,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00415-024-12859-3","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T07:55:24Z","timestamp":1736927724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal visual outcomes in idiopathic intracranial hypertension: the role of early prognostic indicators and risk stratification in disease management"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-4378","authenticated-orcid":false,"given":"Blake D.","family":"Colman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Ngoc","family":"Le Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuvir","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subahari","family":"Raviskanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Del Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Shuey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth J.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"12859_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332222","author":"BD Colman","year":"2023","unstructured":"Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O et al (2023) Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2023-332222","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"12859_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WNO.0b013e31823f852d","volume":"33","author":"AJ Szewka","year":"2013","unstructured":"Szewka AJ, Bruce BB, Newman NJ, Biousse V (2013) Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 33(1):4\u20138","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"12859_CR3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","volume":"76","author":"NJ Adderley","year":"2019","unstructured":"Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP et al (2019) Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol 76(9):1088\u20131098","journal-title":"JAMA Neurol"},{"key":"12859_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145346","author":"CS Westgate","year":"2021","unstructured":"Westgate CS, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G et al (2021) Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.145346","journal-title":"JCI Insight."},{"issue":"3","key":"12859_CR5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41433-018-0238-5","volume":"33","author":"SP Mollan","year":"2019","unstructured":"Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ (2019) The expanding burden of idiopathic intracranial hypertension. Eye (Lond) 33(3):478\u2013485","journal-title":"Eye (Lond)"},{"issue":"1","key":"12859_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s10194-021-01283-x","volume":"22","author":"M Witry","year":"2021","unstructured":"Witry M, Kindler C, Weller J, Linder A, W\u00fcllner U (2021) The patients\u2019 perspective on the burden of idiopathic intracranial hypertension. J Headache Pain 22(1):67","journal-title":"J Headache Pain"},{"issue":"8","key":"12859_CR7","doi-asserted-by":"crossref","first-page":"e1251","DOI":"10.1212\/WNL.0000000000011463","volume":"96","author":"L Miah","year":"2021","unstructured":"Miah L, Strafford H, Fonferko-Shadrach B, Hollinghurst J, Sawhney IM, Hadjikoutis S et al (2021) Incidence, prevalence and healthcare outcomes in idiopathic intracranial hypertension: a population study. Neurology 96(8):e1251\u2013e1261","journal-title":"Neurology"},{"key":"12859_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1874364101307010026","volume":"7","author":"J Best","year":"2013","unstructured":"Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 7:26\u201329","journal-title":"Open Ophthalmol J"},{"issue":"5","key":"12859_CR9","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1167\/iovs.14-14243","volume":"55","author":"JL Keltner","year":"2014","unstructured":"Keltner JL, Johnson CA, Cello KE, Wall M (2014) Baseline visual field findings in the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 55(5):3200\u20133207","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"12859_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0039-1698744","volume":"39","author":"SR Ahmad","year":"2019","unstructured":"Ahmad SR, Moss HE (2019) Update on the diagnosis and treatment of idiopathic intracranial hypertension. Semin Neurol 39(6):682\u2013691","journal-title":"Semin Neurol"},{"issue":"6","key":"12859_CR11","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1167\/iovs.15-16450","volume":"56","author":"JJ Chen","year":"2015","unstructured":"Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M et al (2015) Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56(6):3850\u20133859","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"12859_CR12","first-page":"23","volume":"57","author":"AO KesK\u0131n","year":"2020","unstructured":"KesK\u0131n AO, \u0130d\u0131man F, Kaya D, B\u0131rcan B (2020) Idiopathic intracranial hypertension: etiological factors, clinical features, and prognosis. Noro Psikiyatr Ars 57(1):23\u201326","journal-title":"Noro Psikiyatr Ars"},{"issue":"10","key":"12859_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89(10):1088\u20131100","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"12859_CR14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.0000000000001896","volume":"85","author":"M Wall","year":"2015","unstructured":"Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA et al (2015) Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology 85(9):799\u2013805","journal-title":"Neurology"},{"key":"12859_CR15","doi-asserted-by":"crossref","first-page":"5348928","DOI":"10.1155\/2017\/5348928","volume":"2017","author":"C Chagot","year":"2017","unstructured":"Chagot C, Blonski M, Machu JL, Bracard S, Lacour JC, Richard S (2017) Idiopathic intracranial hypertension: prognostic factors and multidisciplinary management. J Obes 2017:5348928","journal-title":"J Obes"},{"issue":"1","key":"12859_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0972-2327.78044","volume":"14","author":"NN Baheti","year":"2011","unstructured":"Baheti NN, Nair M, Thomas SV (2011) Long-term visual outcome in idiopathic intracranial hypertension. Ann Indian Acad Neurol 14(1):19\u201322","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"12859_CR17","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00415-015-7838-9","volume":"262","author":"JC Kattah","year":"2015","unstructured":"Kattah JC, Pula JH, Mejico LJ, McDermott MP, Kupersmith MJ, Wall M (2015) CSF pressure, papilledema grade, and response to acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neurol 262(10):2271\u20132274","journal-title":"J Neurol"},{"issue":"2","key":"12859_CR18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00415-022-11402-6","volume":"270","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW et al (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol 270(2):851\u2013863","journal-title":"J Neurol"},{"issue":"4","key":"12859_CR19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/WNO.0000000000000751","volume":"39","author":"HE Moss","year":"2019","unstructured":"Moss HE, Joslin CE, Rubin DS, Roth S (2019) Big data research in neuro-ophthalmology: promises and pitfalls. J Neuroophthalmol 39(4):480\u2013486","journal-title":"J Neuroophthalmol"},{"issue":"13","key":"12859_CR20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165","journal-title":"Neurology"},{"issue":"8","key":"12859_CR21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","volume":"45","author":"FJ Durcan","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45(8):875\u2013877","journal-title":"Arch Neurol"},{"key":"12859_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1993.00540010072020","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O\u2019Fallon WM (1993) Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn 1976 to 1990. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.1993.00540010072020","journal-title":"Arch Neurol"},{"issue":"5","key":"12859_CR23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","volume":"124","author":"KP Kilgore","year":"2017","unstructured":"Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD et al (2017) Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology 124(5):697\u2013700","journal-title":"Ophthalmology"},{"issue":"1","key":"12859_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/112067210401400108","volume":"14","author":"A Carta","year":"2004","unstructured":"Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S (2004) Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol 14(1):48\u201354","journal-title":"Eur J Ophthalmol"},{"key":"12859_CR25","doi-asserted-by":"publisher","DOI":"10.4321\/S0365-66912007000400006","author":"VM Asensio-S\u00e1nchez","year":"2007","unstructured":"Asensio-S\u00e1nchez VM, Merino-Angulo J, S. MC. (2007) Epidemiologia del pseudotumor cerebral. ARch Soc Esp Oftalmol. https:\/\/doi.org\/10.4321\/S0365-66912007000400006","journal-title":"ARch Soc Esp Oftalmol"},{"issue":"2","key":"12859_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nrl.2013.08.009","volume":"30","author":"Y Contreras-Martin","year":"2015","unstructured":"Contreras-Martin Y, Bueno-Perdomo JH (2015) Idiopathic intracranial hypertension: descriptive analysis in our setting. Neurologia 30(2):106\u2013110","journal-title":"Neurologia"},{"issue":"1","key":"12859_CR27","first-page":"31","volume":"70","author":"JJ Craig","year":"2001","unstructured":"Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991\u20131995). Ulster Med J 70(1):31\u201335","journal-title":"Ulster Med J"},{"issue":"1","key":"12859_CR28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000435919","volume":"45","author":"G McCluskey","year":"2015","unstructured":"McCluskey G, Mulholland DA, McCarron P, McCarron MO (2015) Idiopathic intracranial hypertension in the northwest of northern ireland: epidemiology and clinical management. Neuroepidemiology 45(1):34\u201339","journal-title":"Neuroepidemiology"},{"issue":"10","key":"12859_CR29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1468-1331.2011.03372.x","volume":"18","author":"N Raoof","year":"2011","unstructured":"Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield. UK Eur J Neurol 18(10):1266\u20131268","journal-title":"UK Eur J Neurol"},{"issue":"2","key":"12859_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0036933018809727","volume":"64","author":"C Goudie","year":"2019","unstructured":"Goudie C, Burr J, Blaikie A (2019) Incidence of idiopathic intracranial hypertension in Fife. Scott Med J 64(2):62\u201366","journal-title":"Scott Med J"},{"issue":"14","key":"12859_CR31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1177\/03331024211024166","volume":"41","author":"A Sundholm","year":"2021","unstructured":"Sundholm A, Burkill S, Waldenlind E, Bahmanyar S, Nilsson Remahl AIM (2021) A national Swedish case-control study investigating incidence and factors associated with idiopathic intracranial hypertension. Cephalalgia 41(14):1427\u20131436","journal-title":"Cephalalgia"},{"issue":"6","key":"12859_CR32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s004150070182","volume":"247","author":"I Yabe","year":"2000","unstructured":"Yabe I, Moriwaka F, Notoya A, Ohtaki M, Tashiro K (2000) Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J Neurol 247(6):474\u2013475","journal-title":"J Neurol"},{"key":"12859_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211006566","author":"O Rehman","year":"2021","unstructured":"Rehman O, Ichhpujani P, Kumar S, Saroa R, Sawal N (2021) Idiopathic intracranial hypertension and visual function in North Indian population. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721211006566","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"12859_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0022-510X(93)90084-C","volume":"116","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE (1993) Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 116(1):18\u201328","journal-title":"J Neurol Sci"},{"issue":"8","key":"12859_CR35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/ene.12442","volume":"21","author":"A Kesler","year":"2014","unstructured":"Kesler A, Stolovic N, Bluednikov Y, Shohat T (2014) The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol 21(8):1055\u20131059","journal-title":"Eur J Neurol"},{"issue":"3","key":"12859_CR36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-620X.122276","volume":"6","author":"T Idiculla","year":"2013","unstructured":"Idiculla T, Zachariah G, Br K, Mohamood N (2013) The incidence and prevalance of idiopathic intracranial hypertension in south Sharaqiah region. Oman Oman J Ophthalmol 6(3):189\u2013192","journal-title":"Oman Oman J Ophthalmol"},{"key":"12859_CR37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fneur.2020.00672","volume":"11","author":"JY Al-Hashel","year":"2020","unstructured":"Al-Hashel JY, Ismail II, Ibrahim M, John JK, Husain F, Kamel WA et al (2020) Demographics, clinical characteristics, and management of idiopathic intracranial hypertension in kuwait: a single-center experience. Front Neurol 11:672","journal-title":"Front Neurol"},{"issue":"6","key":"12859_CR38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","volume":"71","author":"M Wall","year":"2014","unstructured":"Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI et al (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693\u2013701","journal-title":"JAMA Neurol"},{"key":"12859_CR39","volume":"205","author":"W Xu","year":"2021","unstructured":"Xu W, Prime Z, Papchenko T, Danesh-Meyer HV (2021) Long term outcomes of idiopathic intracranial hypertension: observational study and literature review. Clin Neurol Neurosurg 205:106463","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"12859_CR40","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.4081\/ni.2017.7280","volume":"9","author":"F Sina","year":"2017","unstructured":"Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M (2017) Migraine headache in patients with idiopathic intracranial hypertension. Neurol Int 9(3):7280","journal-title":"Neurol Int"},{"issue":"Suppl 1","key":"12859_CR41","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1007\/s10072-013-1388-7","volume":"34","author":"D D'Amico","year":"2013","unstructured":"D\u2019Amico D, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G et al (2013) Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci 34(Suppl 1):S147\u2013S149","journal-title":"Neurol Sci"},{"key":"12859_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2023.11.005","volume":"292","author":"N Rzewuska","year":"2024","unstructured":"Rzewuska N, Kunicki J, Pieniak K, Laskus P, Zabielska B, Smolarczyk R et al (2024) A systematic review on idiopathic intracranial hypertension comorbid with polycystic ovarian syndrome and its consequences. Eur J Obstet Gynecol Reprod Biol 292:1\u20137","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"17","key":"12859_CR43","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1038\/s41433-023-02569-x","volume":"37","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Sassani M, Mollan SP, Sinclair AJ (2023) Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome. Eye (Lond) 37(17):3621\u20133628","journal-title":"Eye (Lond)"},{"issue":"18","key":"12859_CR44","doi-asserted-by":"crossref","first-page":"e1968","DOI":"10.1212\/WNL.0000000000201064","volume":"99","author":"NJ Adderley","year":"2022","unstructured":"Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ (2022) Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology 99(18):e1968\u2013e1978","journal-title":"Neurology"},{"issue":"1","key":"12859_CR45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01658107.2022.2162089","volume":"47","author":"M Thaller","year":"2023","unstructured":"Thaller M, Adderley NJ, Subramanian A, Mollan SP, Sinclair AJ (2023) Co-morbid polycystic ovarian syndrome with idiopathic intracranial hypertension. Neuroophthalmology 47(1):49\u201352","journal-title":"Neuroophthalmology"},{"key":"12859_CR46","volume":"2012","author":"I Avisar","year":"2012","unstructured":"Avisar I, Gaton DD, Dania H, Stiebel-Kalish H (2012) The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension. Scientifica (Cairo) 2012:708042","journal-title":"Scientifica (Cairo)"},{"issue":"2","key":"12859_CR47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajo.12730","volume":"58","author":"LC Varanasi","year":"2018","unstructured":"Varanasi LC, Subasinghe A, Jayasinghe YL, Callegari ET, Garland SM, Gorelik A et al (2018) Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16\u201329 years. Aust N Z J Obstet Gynaecol 58(2):222\u2013233","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"12859_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200548","author":"JJ Korsb\u00e6k","year":"2022","unstructured":"Korsb\u00e6k JJ, Beier D, Hagen SM, Molander LD, Jensen RH (2022) Psychiatric comorbidities in patients with idiopathic intracranial hypertension: a prospective cohort study. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000200548","journal-title":"Neurology"},{"issue":"2","key":"12859_CR49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/01658107.2021.1984540","volume":"46","author":"R Behbehani","year":"2022","unstructured":"Behbehani R, Ali A, Al-Moosa A (2022) Course and predictors of visual outcome of idiopathic intracranial hypertension. Neuroophthalmology 46(2):80\u201384","journal-title":"Neuroophthalmology"},{"issue":"7","key":"12859_CR50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/aos.13664","volume":"96","author":"CF Hatem","year":"2018","unstructured":"Hatem CF, Yri HM, S\u00f8rensen AL, Wegener M, Jensen RH, Hamann S (2018) Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension. Acta Ophthalmol 96(7):719\u2013723","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"12859_CR51","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9394(14)73425-7","volume":"96","author":"M Wall","year":"1983","unstructured":"Wall M, Hart WM Jr, Burde RM (1983) Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 96(5):654\u2013669","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"12859_CR52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1167\/iovs.15-18626","volume":"57","author":"M Wall","year":"2016","unstructured":"Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL (2016) Visual field outcomes for the idiopathic intracranial hypertension treatment trial (IIHTT). Invest Ophthalmol Vis Sci 57(3):805\u2013812","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"12859_CR53","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1007\/s00415-024-12481-3","volume":"271","author":"M Prem Senthil","year":"2024","unstructured":"Prem Senthil M, Anand S, Chakraborty R, Bordon JE, Constable PA, Brown S et al (2024) Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review. J Neurol 271(8):4769\u20134793","journal-title":"J Neurol"},{"issue":"12","key":"12859_CR54","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1167\/iovs.14-14960","volume":"55","author":"P Auinger","year":"2014","unstructured":"Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J et al (2014) Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci 55(12):8180\u20138188","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"12859_CR55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/01658107.2018.1476558","volume":"43","author":"G Athappilly","year":"2019","unstructured":"Athappilly G, Garc\u00eda-Basterra I, Machado-Miller F, Hedges TR, Mendoza-Santiesteban C, Vuong L (2019) Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension. Neuroophthalmology 43(1):10\u201317","journal-title":"Neuroophthalmology"},{"issue":"4","key":"12859_CR56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajo.2006.12.040","volume":"143","author":"AB Daniels","year":"2007","unstructured":"Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 143(4):635\u2013641","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"12859_CR57","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/jwh.2009.1804","volume":"19","author":"MK Baldwin","year":"2010","unstructured":"Baldwin MK, Lobb B, Tanne E, Egan R (2010) Weight and visual field deficits in women with idiopathic intracranial hypertension. J Womens Health (Larchmt) 19(10):1893\u20131898","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"12859_CR58","first-page":"155","volume":"114","author":"M Wall","year":"1991","unstructured":"Wall M, George D (1991) Idiopathic intracranial hypertension. a prospective study of 50 patients. Brain 114(1):155\u2013180","journal-title":"Brain"},{"issue":"2","key":"12859_CR59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00415-010-5750-x","volume":"258","author":"M Skau","year":"2011","unstructured":"Skau M, Sander B, Milea D, Jensen R (2011) Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 258(2):277\u2013283","journal-title":"J Neurol"},{"issue":"8","key":"12859_CR60","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s00415-002-0791-4","volume":"249","author":"R Huna-Baron","year":"2002","unstructured":"Huna-Baron R, Kupersmith MJ (2002) Idiopathic intracranial hypertension in pregnancy. J Neurol 249(8):1078\u20131081","journal-title":"J Neurol"},{"issue":"5","key":"12859_CR61","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11910-004-0087-4","volume":"4","author":"RA Tang","year":"2004","unstructured":"Tang RA, Dorotheo EU, Schiffman JS, Bahrani HM (2004) Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep 4(5):398\u2013409","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"15","key":"12859_CR62","doi-asserted-by":"crossref","first-page":"e1598","DOI":"10.1212\/WNL.0000000000206854","volume":"100","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Mollan SP, Sinclair AJ (2023) Disease course and long-term outcomes in pregnant women with idiopathic intracranial hypertension: the IIH prospective maternal health study. Neurology 100(15):e1598\u2013e1610","journal-title":"Neurology"},{"issue":"1","key":"12859_CR63","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200226","volume":"14","author":"V Vukovic-Cvetkovic","year":"2024","unstructured":"Vukovic-Cvetkovic V, Beier D, Buchgreitz L, Korsbaek JJ, Jensen RH (2024) Management and outcome of pregnancy in patients with idiopathic intracranial hypertension: a prospective case series study. Neurol Clin Pract 14(1):e200226","journal-title":"Neurol Clin Pract"},{"key":"12859_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17241","author":"M Thaller","year":"2022","unstructured":"Thaller M, Mytton J, Wakerley BR, Mollan SP, Sinclair AJ (2022) Idiopathic intracranial hypertension: evaluation of births and fertility through the hospital episode statistic dataset. BJOG. https:\/\/doi.org\/10.1111\/1471-0528.17241","journal-title":"BJOG"},{"key":"12859_CR65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clineuro.2019.02.013","volume":"179","author":"CU Onyia","year":"2019","unstructured":"Onyia CU, Ogunbameru IO, Dada OA, Owagbemi OF, Ige-Orhionkpaibima FS, Olarewaju OA et al (2019) Idiopathic intracranial hypertension: proposal of a stratification strategy for monitoring risk of disease progression. Clin Neurol Neurosurg 179:35\u201341","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"12859_CR66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10194-023-01641-x","volume":"24","author":"G Bsteh","year":"2023","unstructured":"Bsteh G, Marik W, Krajnc N, Macher S, Mitsch C, Pruckner P et al (2023) MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J Headache Pain 24(1):97","journal-title":"J Headache Pain"},{"issue":"3","key":"12859_CR67","doi-asserted-by":"crossref","first-page":"333102423115279","DOI":"10.1177\/03331024231152795","volume":"43","author":"JJ Korsbaek","year":"2023","unstructured":"Korsbaek JJ, Jensen RH, Hogedal L, Molander LD, Hagen SM, Beier D (2023) Diagnosis of idiopathic intracranial hypertension: a proposal for evidence-based diagnostic criteria. Cephalalgia 43(3):3331024231152795","journal-title":"Cephalalgia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12859-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T11:41:13Z","timestamp":1739619673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12859-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12859"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12859-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BDC, PGS, AF, MNLN, RK, RC, SS, SR, NS, EH, and CLF report no conflicts. JF receives funding from Genzyme and Biogen and has received honorarium from Novartis. OW has received honoraria from Novartis, Merck, and Genzyme, and has served on Advisory Boards for Merck, Novartis, Roche, and Biogen. He is Chief Medical Officer for Braineye P\/L. LDP has received research funding from Alcon laboratories. AVDW has served on advisory boards for Novartis, Biogen, Merck and Roche and NervGen. She received unrestricted research grants from Novartis, Biogen, Merck, and Roche. She is currently a co-Principal investigator on a co-sponsored observational study with Roche, evaluating a Roche-developed smartphone app, Floodlight-MS. She has received speaker\u2019s honoraria and travel support from Novartis, Roche, Biogen, and Merck. She serves as the Chief operating Officer of the MSBase Foundation (not for profit). Her primary research support is from the National Health and Medical Research Council of Australia and MS Research Australia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study has been approved by the Human Research Ethics Committee of Alfred Health (Project No. 53125, local reference number 312\/19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"108"}}